Aflibercept for the Treatment of Age-Related Macular Degeneration
Aflibercept is a novel, recombinant, fusion protein that consists of portions of vascular endothelial growth factor (VEGF) receptor (R) 1 and VEGFR2 extracellular domains fused to the Fc portion of human immunoglobulin G1. It exhibits higher affinity for VEGF-A/-B and binds all the VEGF isoforms (VE...
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Springer Healthcare
2013
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108145/ |